Financial insights of IMCR

MyFinsight

For the year ending 2025-12-31, IMCR made $400,016K in revenue. -$29,835K in net income. Net profit margin of -7.46%.

Income Statement	2025-12-31
Total revenue	400,016
Cost of revenue from sale of therapies	5,087
Research and development expense	274,869
Selling, general and administrative expense	165,413
Loss from operations	-45,353
Interest income	16,476
Interest expense	12,166
Foreign currency gain (loss)	2,215
Other income (expense), net	19,728
Net loss before income taxes	-19,100
Income tax (expense) benefit	16,414
Net loss	-35,514
Exchange differences on translation of foreign operations	5,679
Total comprehensive loss	-29,835

Basic EPS	-0.71
Diluted EPS	-0.71
Basic Average Shares	50,345,666
Diluted Average Shares	50,345,666

Unit: Thousand (K) dollars (except for numbers of shares and EPS).